CD36 and melanoma: Furthermore, THP1 and HLEC cells were treated with melanoma-derived EVs for 24 h, and we detected the upregulation of CD36 for both human monocytic-THP1 and human LN endothelial cells with an approximately two- to five-fold change (Figure 2C).